Article
New York-Eyetech Pharmaceuticals Inc.'s sales force will help sell Pfizer Inc.'s once-daily latanoprost ophthalmic solution (Xalatan) to U.S. ophthalmologists.
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.